Strategic Radiology Recruits Scott Bundy, MD, FACR, as Strategic Radiology CEO
Share Article
The Strategic Radiology (SR) coalition of independent practices has recruited one of its own, neuroradiologist Scott Bundy, MD, FACR, as CEO, replacing Arl Van Moore Jr, MD, FACR, who retired this month as CEO and Chair.
Scott Bundy, MD, FACR
I am both honored and humbled to assume the position of CEO of Strategic Radiology and Chair of the Board following the distinguished leadership of Dr. Moore. We have our roadmap, and I am excited to begin executing on that. DALLAS and FORTH WORTH, Texas (PRWEB) January 07, 2021
UT Southwestern Medical Center Elevates its Campus Parking Experience with a Park Assist Parking Guidance System
Thursday, January 7, 2021 12:54 PM
Park Assist, recently merged with TKH Security, has been awarded the Parking Guidance System (PGS) contract for the University of Texas Southwestern Medical Center (UTSW Medical Center) in Dallas, Texas. UTSW is one of the premier academic medical centers in the nation. With over 15,000 employees and faculty and over 2.7 million outpatient visits per year, UT Southwestern is the largest medical school in the University of Texas System and the state of Texas. TKH Security (Park Assist) will install its proprietary camera-based M4 smart sensor system in the Clements Visitor Garage, one of 15 parking facilities on campus. This will be the first parking guidance system to be utilized on the UTSW campus.
In this series of images, purified bacterial transcription factor in solution acts like a fluid by condensing into spherical droplets that then fuse together. Researchers are studying whether condensates might play a role in regulating bacterial cells as well as eukaryotic ones.
James Wall
Last summer, Weber published a study showing that in cells of slow-growing
E. coli bacteria, the RNA polymerase enzyme is uniformly distributed, but in fast-growing cells it clusters in droplets. The fast-growing cells may need to concentrate the polymerase around ribosomal genes to synthesize ribosomal RNA efficiently.
âIt looks like it [phase separation] is in all domains of life, and a universal mechanism that has then been able to specialize into a whole bunch of different functions,â Weber said.
Clene Nanomedicine Closes Merger with Tottenham Acquisition I Limited and Provides Corporate Update
Common stock of the merged company, Clene Inc., to commence trading on the NASDAQ Capital Market under the ticker symbol “CLNN” on December 31, 2020
Clinical pipeline includes an ongoing Phase 3 study in amyotrophic lateral sclerosis (ALS) and four concurrent Phase 2 studies in ALS, multiple sclerosis and Parkinson’s disease
Proceeds from the transaction totaled approximately $31.9 million, combining funds held in Tottenham’s trust account and a concurrent $22.4 million PIPE financing
SALT LAKE CITY, Dec. 30, 2020 (GLOBE NEWSWIRE) Clene Nanomedicine, Inc. (“Clene”) (NASDAQ: CLNN), a clinical-stage biopharmaceutical company, today announced the closing of a merger with Tottenham Acquisition I Limited (“Tottenham”) and provided a corporate update. Proceeds from this transaction totaled approximately $31.9 million, which included funds held in Tottenham’s trust ac